Cardinal Health is upgraded to a buy after Q2 2026 delivered robust revenue, margin expansion, and raised full-year guidance. Q2 revenue grew 19% YoY to $65.6B, with non-GAAP EPS up 36% and ...

Pharmaceutical distributor Cardinal Health is eyeing an expanded footprint in the specialty medicine space through the planned acquisitions of GI Alliance (GIA) and Advanced Diabetes Supply Group (DSG ...

Cardinal Health continues expanding specialty healthcare initiatives as theranostics, precision medicine, and healthcare ...

Cardinal Health, which manufactures and distributes medical and laboratory products, has entered into a definitive agreement to acquire Integrated Oncology Network, a physician-led independent ...

Pharmaceutical distributor Cardinal Health (CAH) on Tuesday said its multi-specialty management services organization (MSO) platform is set to acquire healthcare platform Solaris Health. Cardinal ...

Feb 5 (Reuters) - Cardinal Health on ‌Thursday raised its 2026 profit ‌outlook after beating quarterly results estimates on strong demand for specialty medicines, sending shares up more than 9% in ...

For $1.9 billion in cash, Cardinal Health plans to acquire Solaris Health, a urology management services organization, according to an Aug. 12 news release. After the acquisition, which is expected to ...

Research confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes. The ...

Cardinal Health Inc. (NYSE: CAH) is a global pharmaceutical and medical products distributor serving over 100,000 hospitals. It’s also the largest distributor of medical supplies and surgical products ...